Privia Health (US:PRVA) ZACKS·2026-02-27 15:55Group 1 - Shares of Privia Health (PRVA) have increased by 8.9% over the past four weeks, closing at $24.91, with a mean price target of $31.25 indicating a potential upside of 25.5% [1] - The mean estimate consists of 20 short-term price targets with a standard deviation of $2.99, where the lowest estimate is $23.00 (7.7% decline) and the highest is $37.00 (48.5% increase) [2] - Analysts show strong agreement in revising earnings estimates higher, which correlates with potential stock price movements, as indicated by a 1.7% increase in the Zacks Consensus Estimate for the current year [11][12] Group 2 - PRVA holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, suggesting a strong potential upside [13] - While price targets are often viewed as misleading, the direction indicated by the consensus price target may serve as a useful guide for investors [10][14] - Analysts' price targets can be influenced by business relationships, leading to potentially inflated estimates, but a low standard deviation among targets suggests a consensus on price movement direction [8][9]